Extreme social anxiety, clinically diagnosed as Social Anxiety Disorder (SAD), involves intense, persistent fear of being scrutinised or humiliated in social situations. It affects an estimated 7% of American adults annually—about 15 million people. This goes far beyond shyness; it is a debilitating condition that can prevent work, school attendance, and relationships.
Symptoms affect the mind, body, and behaviour. Physical: blushing, sweating, trembling, rapid heartbeat, nausea. Cognitive: fear of judgment, catastrophic thoughts about humiliation, and anticipatory worry lasting weeks. Behavioural: active avoidance of social settings or enduring them with intense distress. Diagnosis requires persistence for 6 months or more with a clinically significant impairment.
Two distinct types exist. Generalised social anxiety involves fear of all social situations—conversations, eating in public, parties. Performance-only is limited to specific situations like public speaking. Onset occurs early; more than 75% experience first symptoms by age 13. Causes include amygdala hyperactivity, serotonin imbalances, childhood trauma, bullying, and overprotective parenting.
Extreme social anxiety is highly treatable. Gold-standard interventions include Cognitive Behavioural Therapy (CBT) and exposure therapy, with individual CBT showing large effect sizes (SMD -1.19). SSRIs like sertraline show response rates around 50%. With professional help, the vast majority can reclaim their lives.
